The University of Maryland School of Medicine, located in Baltimore City, Maryland, U.S., is the medical school of the University of Maryland, Baltimore and is affiliated with the University of Maryland Medical Center and Medical System. Established in 1807 as the College of Medicine of Maryland, it is the first public and the fifth oldest medical school in the United States. UMB SOM's campus includes Davidge Hall, which was built in 1812, and is the oldest building in continuous use for medical education in the Northern Hemisphere.
Rick Antonius Kittles is an American biologist specializing in human genetics and a Senior Vice President for Research at the Morehouse School of Medicine. He is of African-American ancestry, and achieved renown in the 1990s for his pioneering work in tracing the ancestry of African Americans via DNA testing.
The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.
Joseph W. Cullen was an American cancer prevention and rehabilitation researcher and briefly director of the AMC Cancer Research Center (1989-1990). He previously worked at the VA Hospital in Maryland (1968-1973), the National Institutes of Health (1973), the National Cancer Institute (NCI), and the Jonsson Comprehensive Cancer Center (1976-1982), holding high-level positions such as division director at several. He was a coordinator, creator, and researcher for the Smoking Tobacco and Cancer Program at the NCI, the largest anti-smoking campaign in the world at that time. Cullen wrote more than 90 publications in his lifetime, including four books.
Edison T. Liu, M.D. is the former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center (2012-2021). As CEO of The Jackson Laboratory, the organization doubled revenue, faculty and personnel, expanded globally from two campuses to six, established 13 endowed chairs, and increased the institutional endowment by five-fold. He is currently a Professor and Honorary Fellow at the institution. Before joining The Jackson Laboratory, he was the founding executive director of the Genome Institute of Singapore (GIS), chairman of the board of the Health Sciences Authority, and president of the Human Genome Organization (HUGO) (2007-2013). As the executive director of the GIS, he brought the institution to international prominence as one of the most productive genomics institutions in the world.
Olufunmilayo I. Olopade, O.O.N. is a hematology oncologist, Associate Dean for Global Health and Walter L. Palmer Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
Otis Webb Brawley is an American physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from July 2007 to November 2018. He is board certified in internal medicine and medical oncology and is a Master of the American College of Physicians, Fellow of the American Society of Clinical Oncology, and a Fellow of the American College of Epidemiology. He is a member of the Institute of Medicine now known as the National Academy of Medicine.
University College Hospital, Ibadan is a federal teaching hospital in Ibadan, Nigeria attached to the University of Ibadan.
Professor Minesh P. Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades.
Eric P. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital at Yale New Haven Health, effective February 1, 2022. He also is Deputy Dean for Cancer Programs at the Yale School of Medicine. From 1997 to 2021, he was the Chief of the Breast Oncology Program at Dana–Farber Cancer Institute in Boston, Massachusetts. Beginning in 2013, he held a range of institutional roles at Dana-Farber, including Chief of Clinical Development, the Thompson Chair in Breast Cancer Research and Director of the Dana-Farber/Harvard SPORE in Breast Cancer. He also served as a Professor of Medicine at Harvard Medical School. He was president of the American Society of Clinical Oncology (ASCO) 2022-2023 and became Chair of the Board in mid-June 2023. His career has been focused on breast cancer treatment and research.
Adeyinka Gladys Falusi, FAS NPOM, is a Nigerian Professor of haematology and former Director of the Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan.
Akinyinka Omigbodun is a Nigerian professor of Gynecology, Obstetrics and former provost of the College of Medicine, University of Ibadan. He served as president of the West African College of Surgeons and chair of the management board of the Consortium for Advanced Research Training in Africa (CARTA).
Isaac Folorunso AdewoleFAS is a Nigerian professor of gynaecology and obstetrics. He was minister of health of Nigeria from November 2015 to May 2019 under the Cabinet of President Muhammadu Buhari. He is a former vice-chancellor of the University of Ibadan, and president of the African Organisation for Research and Training in Cancer.
Chinedum Peace BabalolaFAS, FAAS is a Nigerian Professor of Pharmaceutical chemistry and Pharmacokinetics. She is the first female Professor of Pharmacy in the University of Ibadan, FAS and FAAS and the second female Nigerian FAAS. She is the incumbent Vice Chancellor of Chrisland University, Nigeria.
Daniel D. Von Hoff is the physician in chief and director of translational research at Translational Genomics Research Institute (TGen), and current Virginia G. Piper Distinguished Chair for Innovative Cancer Research at HonorHealth Clinical Research Institute. He is also a professor of medicine at the Mayo Clinic and medical director of research as well as chief scientific officer at US Oncology. He is most notable for his work in targeted therapies for the treatment of cancer. He led the development of gemcitabine, and has several drugs in development.
Alash'le Grace Abimiku is a Nigerian executive director of the International Research Centre of Excellence at the Institute of Human Virology Nigeria and a Professor of Virology at the University of Maryland School of Medicine.
Reshma Jagsi is an American Radiation oncologist. She is the Newman Family Professor and Deputy Chair in the Department of Radiation Oncology and Director of the Center for Bioethics and Social Sciences in Medicine at the University of Michigan. Overall, she is the author of over 350 published articles in peer-reviewed medical journals and continues scholarly research in three primary areas of interest: breast cancer, bioethics, and gender equity, with the support of grants from the National Institutes of Health (NIH), the Doris Duke Charitable Foundation, and the Susan G. Komen Foundation, for which she serves as a Senior Scholar.
Howard L. McLeod is an American pharmacogeneticist and implementation scientist specialized in precision medicine.
Folakemi Titilayo Odedina is a Nigerian-born scientist and professor of pharmacy and medicine at the University of Florida. She is the principal investigator for the Prostate Cancer Transatlantic Consortium (CaPTC), a clinical research group using genomic science and environmental etiology to exploring disproportionate burden of prostate cancer among Black men funded by the NCI. She is a member of American Cancer Society's National Prostate Cancer Disparities Advisory Team.
Stephanie Lynn Schutt Graff is an American breast medical oncologist. She is the Director of Breast Oncology at the Lifespan Cancer Institute and an Assistant Professor of Medicine at Alpert Medical School. Previously she was the Director of both the Breast Program and Clinical Research at Sarah Cannon Research Institute at HCA Midwest Health at Sarah Cannon Research Institute and Associate Director of the Breast Cancer Research Program at Sarah Cannon Research Institute.
